Chiron posted a robust increase in fourth-quarter sales and profits yesterday, helped by the resumption of sales for its seasonal influenza vaccine, Fluvirin, and lower taxes. Chiron posted a robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results